S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SUPN Supernus Pharmaceuticals Inc

32.42

-7.33 (-18.44%)

Pre Market

Last Updated: 00:00:22

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Supernus Pharmaceuticals Charts.

Supernus Pharmaceuticals Inc News

Form 8-K - Current report
Wednesday 19 February 2025 (16 hours ago) • Edgar (US Regulatory)

Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
Wednesday 19 February 2025 (16 hours ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 12 February 2025 (1 week ago) • Edgar (US Regulatory)

Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
Wednesday 12 February 2025 (1 week ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 5 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
Wednesday 5 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (3 weeks ago) • Edgar (US Regulatory)

More Supernus Pharmaceuticals Inc News Articles

CubicFarm Systems

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions